Santosh Lamichhane
Academy Research fellow, Adj Prof (Docent), Group Leader,Infection and Immunity Unit at the Institute of Biomedicine.
santosh.lamichhane@utu.fi Link to Research Group ORCID identifier: https://orcid.org/0000-0002-9292-3595 |
Lipidomics/Metabolomics-
Gut microbial metabolism-
Multivariate data analysis
Reverse Metabolomics- Molecular networking
Lamichhane Group- Gut Microbiomics-The focus of our group is to explore microbial derived small molecules in the gut and their influence on human health.
Santosh Lamichhane is the Principal Investigator in the Infection and Immunity Unit at the Institute of Biomedicine. He is a Research Council of Finland Academy Research Fellow and holds the title of Docent (equivalent to Associate Professor) in Metabolomics at the Department of Life Technologies, University of Turku. As part of his research fellowship, Dr. Lamichhane investigates the relationship between gut microbiota, lipids, and their clinical effects in early childhood.
Lamichhane was a Visiting Researcher at The Dorrestein Lab, University of California, San Diego, where he gained expertise in reverse and repository-scale metabolomics to better understand microbial chemistry and its influence on human metabolism.
Lamichhane's research interest lies in the interface of human health, diet and gut microbial activity. He heads a research group (Gut Microbiomics) at Intitute of Biomedicine, Faculty of Medicine. https://sites.utu.fi/gutmicrobiomics/
The focus of his group is to explore microbial derived small molecules in the gut and their influence on human health. By integrating advanced laboratory techniques such as metabolomics, gut organoids, and microbial cultures with computational analysis, we investigate the chemical interactions between gut microbes and their impact on the host.
Metabolomics lecture in Systems biology (SYS21012), Modern biotechnologies and bioinformatics course (BIOT1524), Bioanalytical Techniques (CHEMI6429) at University of Turku.
- Recent advances towards mass spectrometry-based clinical lipidomics (2023)
- Current Opinion in Chemical BiologyBriefings in Bioinformatics
(A2 Refereed review article in a scientific journal ) - Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes (2022)
- Cell Reports MedicineMetabolites
(A1 Refereed original research article in a scientific journal) - (2022)
- Frontiers in NutritionDiabetologia
(A1 Refereed original research article in a scientific journal) - (2021)
- Schizophrenia BulletinEnvironment International
(A1 Refereed original research article in a scientific journal) - Deep learning meets metabolomics: a methodological perspective (2021)
(A2 Refereed review article in a scientific journal ) - Exposure to per- and polyfluoroalkyl substances associates with an altered lipid composition of breast milk (2021)
- Environment International
(A1 Refereed original research article in a scientific journal) - Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations (2021)
(A2 Refereed review article in a scientific journal ) - Systems biology approaches to study lipidomes in health and disease (2021)
- Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids
(A2 Refereed review article in a scientific journal ) - Metabolic alterations in immune cells associate with progression to type 1 diabetes (2020)
(A1 Refereed original research article in a scientific journal) - Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes (2020)
(A1 Refereed original research article in a scientific journal)



